EGFR and neoplasm: EBV T-cell activation only occurred when EGFR was expressed by HeLa-A2 cells, indicating that AEC binding to target positive tumor cells facilitates cleavage of EBV peptide and binding to HLA-A2 expressed by the tumor cells.